Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

References

• Akdemir A, Orsel SD, Dag Iç, İscan N, Ozbay H. Hamilton Depresyon Derecelendirme Olcegi (HDDO)'nin gecerligi-guvenirligi ve klinikte kullanimi (Validity–reliability and clinical use of Turkish version of Hamilton depression rating scale). Psikiyatri Psikol Psikofarmakol Derg 1996; 4: 251–259
   Google Scholar
• Akkaya C, Sivrioglu Y, Sarandol A, Kirli S. Major depresif bozuklukta venlafaksin XR ve reboksetin'in etkililik ve guvenilirliginin karsilastirilmasi (Comparison of venlafaxine XR and reboxetine in terms of efficacy and safety in Major Depressive Disorder). Yeni Symposium 2003; 41: 170–177
   Google Scholar
• American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders4th ed. Washington, DC: American Psychiatric Association.
   Google Scholar
• Amin Z, Canli T, Epperson CN. Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev 2005; 4: 43–58
   PubMedGoogle Scholar
• Amsterdam J, Garcia-Espana F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 1999; 55: 11–17
   PubMed Web of Science ®Google Scholar
• Ayuso-Gutiérrez JL. Depressive subtypes and efficacy of antidepressive pharmacotherapy. World J Biol Psychiatry 2005; 6: 31–37
   PubMed Web of Science ®Google Scholar
• Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 57–65
   PubMed Web of Science ®Google Scholar
• Ballus, C, Quiros, G, De Flores, de la Torre, J, Palao, D, Rojo, L, , et al. 2000. Int Clin Psychopharmacol, 15: 43–48
   PubMed Web of Science ®Google Scholar
• Bano S, Akhter S, Afridi MI. Gender based response to fluoxetine hydrochloride medication in endogenous depression. J Coll Phys Surg Pak 2004; 14: 161–165
   PubMedGoogle Scholar
• Bebbington PE, Dunn G, Jenkins R, Lewis G, Brugha T, Farrell M, et al. The influence of age and sex on the prevalence of depressive conditions: Report from the National Survey of Psychiatric Comorbidity. Psychol Med 1998; 28: 9–19
   PubMed Web of Science ®Google Scholar
• Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG. Quantitative rating of depressive states. Acta Psychiatr Scand 1975; 51: 161–170
   PubMed Web of Science ®Google Scholar
• Berlanga C, Flores-Ramos M. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. J Affect Disord 2006; 95: 119–123
   PubMed Web of Science ®Google Scholar
• Bowden CL, Schatzberg AF, Rosenbaum A, Contreras SA, Samson JA, Dessain E, et al. Fluoxetine and desipramine in major depressive disorder. J Clin Psychopharmacol 1993; 13: 305–310
   PubMed Web of Science ®Google Scholar
• Carlsson M, Carlsson A. A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 53–61
   PubMed Web of Science ®Google Scholar
• Chugani DC, Muzik O, Chakraborty P, Mangner T, Chugani HT. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. Synapse 1998; 28: 33–43
   PubMed Web of Science ®Google Scholar
• Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL. Short term use of estradiol for depression on perimenopausal and postmenopausal women: A preliminary report. Am J Psychiatry 2003; 160: 1519–1522
   PubMed Web of Science ®Google Scholar
• Crowley WR, Filicori M. The physiology of GnRH secretion in man and woman. Recent Prog Horm Res 1985; 41: 473–531
   PubMedGoogle Scholar
• Cyr M, Bosse R, Di Paolo T. Gonadal hormones modulate 5-hydroxytryptamine2A receptors: Emphasis on the rat frontal cortex. Neuroscience 1998; 83: 829–836
   PubMedGoogle Scholar
• De Nayer A, Geerts S, Ruelens L, Schittecatte M, Bleeker E, Van Eeckhoutte I, et al. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety. Int J Neuropsychopharmacol 2002; 5: 115–120
   PubMed Web of Science ®Google Scholar
• DeJonghe F, Ravelli DP, Tuynmna-Qua H. A randomized, double blind study of fluoxetine and maprotiline in the treatment of major depression. Pharmacopsychiatry 1991; 24: 62–67
   PubMedGoogle Scholar
• Dickinson SL, Curzon G. 5-Hydroxytryptamine-mediated behavior in male and female rats. Neuropharmacology 1986; 25: 771–776
   PubMedGoogle Scholar
• Eker SS, Akkaya C, Akgoz S, Sarandol A, Kirli S. Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder. Turk Psikiyatri Derg 2005; 16: 153–163
   PubMed Web of Science ®Google Scholar
• Ellenbogen MA, Young SN, Dean P, Palmour RM, Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers: Sex differences and temporal stability. Neuropsychopharmacology 1996; 15: 465–474
   PubMed Web of Science ®Google Scholar
• Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001; 62: 869–877
   PubMed Web of Science ®Google Scholar
• Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: Effect on mood, mental state and memory. Cell Mol Neurobiol 1996; 16: 325–344
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Kennedy SH, Bagby RM. A comparison of antidepressant response in younger and older women. J Clinl Psychopharmacol 2003; 23: 405–407
   PubMedGoogle Scholar
• Goodwin RD, Gotlib IH. Gender differences in depression: The role of personality factors. Psychiatry Res 2004; 126: 135–142
   PubMed Web of Science ®Google Scholar
• Guy, W. 1976. ECDEU Assessment Manual for Psychopharmacology. Revised US Dept Health, Education and Welfare publication (ADM). Rockville, MD, National Institute of Mental Health.
   Google Scholar
• Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: Pharmacological and clinical profile. CNS Drug Rev 2004; 10: 23–44
   PubMedGoogle Scholar
• Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995; 37: 434–441
   PubMed Web of Science ®Google Scholar
• Haleem DJ, Kennett GA, Curzon G. Hippocampal 5-hydroxytryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT agonist 8-OH-DPAT. J Neural Transm 1990; 79: 93–101
   Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 2000; 57: 503–509
   PubMed Web of Science ®Google Scholar
• Healy D, McMonagle T. The enhancement of social functioning as a therapeutic principle in the management of depression. J Psychopharmacol 1997; 11: 25–31
   Web of Science ®Google Scholar
• Herbison AE. Noradrenergic regulation of cyclic GnRH secretion. Rev Reprod 1997; 2: 1–6
   PubMedGoogle Scholar
• Heritage AS, Grant ID, Stumpf WE. 3H estradiol in catecholamine neurons of rat brain stem: combined localisation by autoradiographic and formaldehyde-induced fluorescence. J Comp Neurol 1977; 176: 607–630
   PubMedGoogle Scholar
• Hildebrandt, MG, Steverberg, EW, Stage, KB, Psschier, J, Kragh-Soerensen, P, Danish University Antidepressant Group. 2003. Are gender differences important for the clinical effects of antidepressants?. Am J Psychiatry, 160: 1643–1650.
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM, Klerman GL, Clayton PJ, Keller MB, Andreasen NC. Personality and gender-related differences in depression. J Affect Disord 1984; 7: 211–221
   PubMedGoogle Scholar
• Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbot RM, et al. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust NZ J Psychiatry 2002; 36: 384–391
   PubMed Web of Science ®Google Scholar
• Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. A longitudinal twin study of 1-year prevalence of major depression in women. Arch Gen Psychiatry 1993; 50: 843–852
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R-psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19
   PubMed Web of Science ®Google Scholar
• Khan A, Brodhead AE, Schwartz KA, Kolts RL, Brown WA. Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 2005; 25: 318–324
   PubMed Web of Science ®Google Scholar
• Kornstein SG. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997; 58: 12–18
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Schatzberg AE, Thase ME. Gender differences in chronic major depression and double depression. J Affect Disord 2000a; 60: 1–11
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Schatzberg AF, Thase ME, Yonker KA, McCullough JP, Keitner GI, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000b; 157: 1445–1452
   PubMed Web of Science ®Google Scholar
• Lepine JP, Caillard V, Bisserbe JC, Troy S, Hotton JM, Boyer P. A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder. Am J Psychiatry 2004; 161: 836–842
   PubMed Web of Science ®Google Scholar
• Martenyi F, Dossenbach M, Mraz K, Metcalfe S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol 2001; 11: 227–232
   PubMed Web of Science ®Google Scholar
• McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997; 48: 8–15
   PubMed Web of Science ®Google Scholar
• Montgomery SA. Reboxetine: additional benefits to the depressed patient. J Psychopharmacol 1997; 11: 9–15
   PubMed Web of Science ®Google Scholar
• Morrison MF, Kallan MJ, Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: A randomized, controlled trial. Biol Psychiatry 2004; 55: 406–412
   PubMed Web of Science ®Google Scholar
• Morse DT. Minsize2: a computer program for determining effect size and minimum sample size for statistical significance for univariate, multivariate, and nonparametric tests. Educ Psychol Meas 1999; 59: 518
   Web of Science ®Google Scholar
• Möller-Leimkühler AM. Women with coronary artery disease and depression: a neglected risk group. World J Biol Psychiatry 2008; 9: 92–101
   PubMed Web of Science ®Google Scholar
• Naito S, Sato K, Yoshida K, Higuchi H, Takahashi H, Kamata M, et al. Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients. Psychiatry Clin Neurosci 2007; 61: 421–427
   PubMed Web of Science ®Google Scholar
• Nelson JC, Portera L, Leon AC. Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor?. Biol Psychiatry 2005a; 57: 1535–1542
   PubMed Web of Science ®Google Scholar
• Nelson JC, Portera L, Leon AC. Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine. J Clin Psychiatry 2005b; 66: 1409–1414
   PubMed Web of Science ®Google Scholar
• Neumeister A. Tryptophan depletion, serotonin, and depression: where do we stand?. Psychopharmacol Bull 2003; 37: 99–115
   PubMedGoogle Scholar
• Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997; 94: 5308–5313
   PubMed Web of Science ®Google Scholar
• Nurnberg HG. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction. Drugs Today (Barc) 2008; 44: 147–168
   PubMed Web of Science ®Google Scholar
• Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: A pooled analysis. J Psychiatr Res 2009; 43: 792–797
   PubMed Web of Science ®Google Scholar
• Quitkin FM, Stewart JW, McGrath PJ, Taylor BP., Tisminetzky MS, Petkova E, et al. Are there differences between women's and men's antidepressant responses?. Am J Psychiatry 2002; 159: 1848–1854
   PubMed Web of Science ®Google Scholar
• Raskin A. Age sex differences in response to antidepressant drugs. J Nerv Ment Dis 1974; 159: 120–130
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998; 44: 839–850
   PubMed Web of Science ®Google Scholar
• Scates AC, Doraiswamy PM. Reboxetine: A selective norepinephrine reuptake inhibitor for the treatment of depression. Ann Pharmacother 2000; 34: 1302–1312
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: A preliminary report. Am J Obstet Gynecol 2000; 183: 414–420
   PubMed Web of Science ®Google Scholar
• Schneider LS, Small GW, Clary C. Estrogen replacement therapy and antidepressant response to sertraline. Am J Geriatr Psychiatry 2001; 9: 393–399
   PubMed Web of Science ®Google Scholar
• Schweizer E, Rynn M, Mandos LA, Demartinis N, Garcia-Espana F, Rickles K. The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial. Int Clin Psychopharmacol 2001; 16: 137–143
   PubMed Web of Science ®Google Scholar
• Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York 1988
   Google Scholar
• Silverstein B. Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am J Psychiatry 1999; 156: 480–482
   PubMed Web of Science ®Google Scholar
• Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo controlled trial. Arch Gen Psychiatry 2001; 58: 529–534
   PubMed Web of Science ®Google Scholar
• Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL, Cohen LS. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry 2003; 64: 473–479
   PubMed Web of Science ®Google Scholar
• Stahl SM, Entsuah R, Rudolph RL. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry 2002; 52: 1166–1174
   PubMed Web of Science ®Google Scholar
• Sumner BE, Fink G. Estrogen increases the density of 5-hydroxytryptamine (2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 1995; 54: 15–20
   PubMed Web of Science ®Google Scholar
• Thase ME, Entsuah R, Cantillon M, Kormstein SG. Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. J Womens Health 2005; 14: 609–616
   PubMed Web of Science ®Google Scholar
• Thiels C, Linden M, Grieger F, Leonard J. Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin Psychopharmacol 2005; 20: 1–7
   PubMedGoogle Scholar
• Yazicioglu B, Akkaya C, Sarandol A, Akgoz S, Eker SS, Kirli S. A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: A randomized, open-labeled clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1271–1276
   PubMed Web of Science ®Google Scholar
• Wang JL. The difference between single and married mothers in the 12-month prevalence of major depressive syndrome, associated factors and mental health service utilization. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 26–32
   PubMed Web of Science ®Google Scholar